Functional impairment in chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivity

Canadian Family Physician

Volumn 56, Issue 2, 2010, Pages

  Lavergne, M Ruth ^g   Cole, Donald C ^a,b,c   Kerr, Kathleen ^d,e   Marshall, Lynn M ^d,e,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b International Potato Center   (Uganda)

^c INSTITUTE FOR WORK AND HEALTH   (Canada)

^d WOMEN S COLLEGE HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; FEMALE; FIBROMYALGIA; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HEALTH CARE UTILIZATION; HUMAN; JOB PERFORMANCE; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CHEMICAL SENSITIVITY; ONSET AGE; OUTCOME ASSESSMENT; SHORT FORM 36; SOCIAL CLASS; SOCIAL STATUS; SOCIOECONOMICS; SYMPTOM; WORK CAPACITY;

ACTIVITIES OF DAILY LIVING; ADULT; CANADA; CASE-CONTROL STUDIES; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; MULTIPLE CHEMICAL SENSITIVITY; PSYCHOMETRICS; REFERENCE VALUES; SOCIAL ADJUSTMENT; SOCIOECONOMIC FACTORS;

EID: 77649325462     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Komaroff AL, Fagioli LR, Doolittle TH, Gandek B, Gleit MA, Guerriero RT, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996;101(3):281-90.
2. Hardt J, Buchwald D, Wilks D, Sharpe M, Nix WA, Egle UT. Health-related quality of life in patients with chronic fatigue syndrome: an international study. J Psychosom Res 2001;51(2):431-4.
3. Reeves WC, Wagner D, Nisenbaum R, Jones JF, Gurbaxani B, Solomon L, et al. Chronic fatigue syndrome - a clinically empirical approach to its definition and study. BMC Med 2005;3:19.
4. Bennett RM, Schein J, Kosinski MR, Hewitt DJ, Jordan DM, Rosenthal NR. Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum 2005;53(4):519-27.
5. Caress SM, Steinemann AC, Waddick C. Symptomatology and etiology of multiple chemical sensitivities in the southeastern United States. Arch Environ Health 2002;57(5):429-36.
6. Black DW, Doebbeling BN, Voelker MD, Clarke WR, Woolson RF, Barrett DH, et al. Quality of life and health-services utilization in a population-based sample of military personnel reporting multiple chemical sensitivities. J Occup Environ Med 1999;41(10):928-33.
7. Jason LA, Taylor RR, Kennedy CL. Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. Psychosom Med 2000;62(5):655-63.
8. Park J, Kudson S. Medically unexplained physical symptoms. Health Rep 2007;18(1):43-7.
9. Bell IR, Baldwin CM, Schwartz GE. Illness from low levels of environmental chemicals: relevance to chronic fatigue syndrome and fibromyalgia. Am J Med 1998;105(3A):74S-82S.
10. Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994;154(18):2049-53.
11. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121(12):953-9.
12. Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 2003;11(1):7-115.
13. Jain AK, Carruthers BM, van de Sande MI, Barron SR, Donaldson CCS, Dunne JV, et al. Fibromyalgia syndrome: Canadian clinical working case definition, diagnostic and treatment protocols - a consensus document. J Musculoskeletal Pain 2003;11(4):3-107.
14. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33(2):160-72.
15. McKeown-Eyssen GE, Baines CJ, Marshall LM, Jazmaji V, Sokoloff ER. Multiple chemical sensitivity: discriminant validity of case definitions. Arch Environ Health 2001;56(5):406-12.
16. Multiple chemical sensitivity: a 1999 consensus. Arch Environ Health 1999;54(3):147-9.
17. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473-83.
18. McKeown-Eyssen GE, Sokoloff ER, Jazmaji V, Marshall LM, Baines CJ. Reproducibility of the University of Toronto self-administered questionnaire used to assess environmental sensitivity. Am J Epidemiol 2000;151(12):1216-22.
19. Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, et al. Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ 2000;163(3):265-71.
20. Hopman WM, Berger C, Joseph L, Towheed T, vandenKerkhof E, Anastassiades T, et al. Stability of normative data for the SF-36: results of a three-year prospective study in middle-aged Canadians. Can J Public Health 2004;95(5):387-91.
21. Herrell R, Goldberg J, Hartman S, Belcourt M, Schmaling K, Buchwald D. Chronic fatigue and chronic fatigue syndrome: a co-twin control study of functional status. Qual Life Res 2002;11(5):463-71.
22. Alanoglu E, Ulas UH, Ozdag F, Odabasi Z, Çakçi A, Vural O. Auditory eventrelated brain potentials in fibromyalgia syndrome. Rheumatol Int 2005;25(5):345-9. Epub 2004 Feb 21.
23. Neumann L, Berzak A, Buskila D. Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 2000;29(6):400-8.
24. Bergman S. Psychosocial aspects of chronic widespread pain and fibromyalgia. Disabil Rehabil 2005;27(12):675-83.
25. Hopman WM, Berger C, Joseph L, Towheed T, Anastassiades T, Tenenhouse A, et al. Is there regional variation in the SF-36 scores of Canadian adults? Can J Public Health 2002;93(3):233-7.
26. Statistics Canada. Canadian Community Health Survey, cycle 3.1. Ottawa, ON: Statistics Canada; 2005.
27. Miller CS. Toxicant-induced loss of tolerance - an emerging theory of disease? Environ Health Perspect 1997;105(Supp 2):445-53.
28. Lax MB, Henneberger PK. Patients with multiple chemical sensitivities in an occupational health clinic: presentation and follow-up. Arch Environ Health 1995;50(6):425-31.
29. Ziem GE. Profile of patients with chemical injury and sensitivity, part II. Int J Toxicol 1999;18(6):401-9.
30. Gibson PR, Elms AN, Ruding LA. Perceived treatment efficacy for conventional and alternative therapies reported by persons with multiple chemical sensitivity. Environ Health Perspect 2003;111(12):1498-504.
31. Mannerkorpi K, Iverson MD. Physical exercise in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 2003;17(4):629-47.
32. Sears ME. The medical perspective on environmental sensitivities. Ottawa, ON: Canadian Human Rights Commission; 2007. Available from: www.chrc-ccdp. ca/pdf/envsensitivity-en.pdf. Accessed 2007 May 17.
33. Kaushik N, Fear D, Richards SC, McDermott CR, Nuwaysir EF, Kellam P, et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol 2005;58(8):826-32.
34. Kerr JR, Christian P, Hodgetts A, Langford PR, Devanur LD, Petty R, et al. Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments. J Clin Pathol 2007;60(2):113-6. Epub 2006 Aug 25.
35. Carlo-Stella N, Badulli C, De Silvestri A, Bazzichi L, Martinetti M, Lorusso L, et al. A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNγ 874 rare alleles. Clin Exp Rheumatol 2006;24(2):179-82.
36. Vernon SD, Whistler T, Cameron B, Hickie IB, Reeves WC, Lloyd A, et al. Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infect Dis 2006;6:15.
37. Gürsoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 2003;23(3):104-7.
38. McKeown-Eyssen G, Baines C, Cole DE, Riley N, Tyndale RF, Marshall L, et al. Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR. Int J Epidemiol 2004;33(5):971-8. Epub 2004 Jul 15.
39. Schnakenberg E, Fabig KR, Stanulla M, Strobl N, Lustig M, Fabig N, et al. A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes. Environ Health 2007;6:6.
40. Kerr JR, Petty R, Burke B, Gough J, Fear D, Sinclair LI, et al. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis 2008;197(8):1171-84.
41. Kerr JR, Mattey DL. Preexisting psychological stress predicts acute and chronic fatigue and arthritis following symptomatic parvovirus B19 infection. Clin Infect Dis 2008;46(9):e83-7.
42. Centers for Disease Control and Prevention [website]. Chronic fatigue syndrome. Health professionals. Atlanta, GA: Department of Health and Human Services; 2006. Available from: www.cdc.gov/cfs/healthcareprofessionals. htm. Accessed 2008 Aug 23.